Loading news...
Danaher (NYSE: DHR) and Thermo Fisher Scientific (NYSE: TMO) both reported Q3 2025 earnings showing revenue growth around 5%, but underlying business momentum tells very different stories.
Dan Deming offers a glimpse into companies outside the AI trade he sees rallying in 2026. He offers bullish perspective and example options trades for Boeing (BA), Danaher (DHR), and Dollar General (DG).
Cerity Partners LLC decreased its position in shares of Danaher Corporation (NYSE: DHR) by 3.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 332,416 shares of the conglomerate's stock after selling 10,460 shares during the quarter. Cerity Partners LLC's holdings in
First Merchants Corp reduced its stake in shares of Danaher Corporation (NYSE: DHR) by 7.0% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,880 shares of the conglomerate's stock after selling 2,614 shares during the period.
WASHINGTON, Jan. 5, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that its President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P.
Railway Pension Investments Ltd raised its position in shares of Danaher Corporation (NYSE: DHR) by 148.4% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 689,899 shares of the conglomerate's stock after buying an additional 412,200 shares during the quarter.
Capital Advisors Inc. OK increased its stake in Danaher Corporation (NYSE: DHR) by 24.6% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 217,130 shares of the conglomerate's stock after purchasing an additional 42,808 shares during the period. Capital
Davis Capital Management purchased a new position in shares of Danaher Corporation (NYSE: DHR) during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 2,273 shares of the conglomerate's stock, valued at approximately $451,000. Several other hedge funds and
Altfest L J and Co. Inc. lessened its stake in Danaher Corporation (NYSE: DHR) by 47.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 5,680 shares of the conglomerate's stock after selling 5,124 shares during the period. Altfest L J and Co.
My Top 15 High-Growth Dividend Stock list delivered a 0.83% gain in December, outperforming SPY and VIG. The Value-tilted portfolio variant led with a 2.17% December return, suggesting undervaluation may drive near-term alpha. Collectively, the January 2026 list offers a 1.35% yield, 16.87% five-year dividend growth, and appears 29% undervalued.
Financial Consulate Inc. bought a new stake in Danaher Corporation (NYSE: DHR) in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 3,753 shares of the conglomerate's stock, valued at approximately $744,000. Other hedge funds have also bought and sold shares of
Generali Asset Management SPA SGR trimmed its holdings in Danaher Corporation (NYSE: DHR) by 5.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 59,821 shares of the conglomerate's stock after selling 3,176 shares during the period. Generali Asset Management
Ascent Group LLC lifted its holdings in Danaher Corporation (NYSE: DHR) by 120.8% in the undefined quarter, according to its most recent 13F filing with the SEC. The firm owned 9,912 shares of the conglomerate's stock after purchasing an additional 5,422 shares during the quarter. Ascent Group LLC's holdings in Danaher were worth
Ramsay Health Care (OTCMKTS:RMYHY - Get Free Report) and Danaher (NYSE: DHR - Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk and analyst recommendations. Dividends Ramsay Health Care pays an annual dividend
Delta Investment Management LLC lowered its stake in shares of Danaher Corporation (NYSE: DHR) by 80.6% during the undefined quarter, according to its most recent filing with the SEC. The firm owned 3,538 shares of the conglomerate's stock after selling 14,745 shares during the period. Delta Investment Management LLC's holdings in Danaher were
Calamos Wealth Management LLC increased its position in Danaher Corporation (NYSE: DHR) by 41.0% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 85,624 shares of the conglomerate's stock after purchasing an additional 24,888 shares during the quarter. Calamos
Calamos Advisors LLC lessened its stake in shares of Danaher Corporation (NYSE: DHR) by 13.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 223,518 shares of the conglomerate's stock after selling 36,163 shares during the period. Calamos
Farmers and Merchants Investments Inc. decreased its stake in shares of Danaher Corporation (NYSE: DHR) by 10.0% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 35,573 shares of the conglomerate's stock after selling 3,950 shares during the quarter. Farmers and Merchants
A low valuation is not enough in the REIT sector. Many of the cheapest REITs are also the worst investments. I highlight many REIT value traps to avoid going into 2026.
Fulton Breakefield Broenniman LLC lessened its holdings in shares of Danaher Corporation (NYSE: DHR) by 6.6% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 66,948 shares of the conglomerate's stock after selling 4,727 shares during the period.